The new Huberman Lab episode covers how food choices affect memory and cravings, including the body's own GLP-1, the drugs, and microdosing.
Recap by typeshit. Post by Andrew D. Huberman, Ph.D. on X.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Olhar Digital reports a Chinese approval for Wegovy, Novo Nordisk's semaglutide shot for weight loss. Few details beyond the headline were given.
The new episode covers how food choices shape memory and cravings, with chapters on natural GLP-1, GLP-1 drugs, microdosing and hunger.
Loading…